USANA Health Sciences (NYSE:USNA) Hits New 1-Year Low – Here’s What Happened

USANA Health Sciences, Inc. (NYSE:USNA) shares hit a new 52-week low on Tuesday . The stock traded as low as $27.58 and last traded at $28.03, with a volume of 59771 shares trading hands. The stock had previously closed at $27.98.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on USNA. Sidoti lowered shares of USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 18th. StockNews.com downgraded shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 14th. Finally, DA Davidson cut their price target on USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating for the company in a report on Thursday, February 27th.

USANA Health Sciences Trading Down 1.1 %

The business has a 50 day moving average of $32.09 and a two-hundred day moving average of $35.63. The firm has a market cap of $514.92 million, a P/E ratio of 9.62, a PEG ratio of 0.93 and a beta of 0.98.

USANA Health Sciences (NYSE:USNA) last released its earnings results on Tuesday, February 25th. The company reported $0.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.49 by $0.15. The company had revenue of $213.61 million for the quarter, compared to analyst estimates of $208.82 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. On average, sell-side analysts predict that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.

Insider Activity

In other news, insider David Mulham Mulham sold 3,234 shares of the business’s stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $32.98, for a total transaction of $106,657.32. Following the completion of the sale, the insider now owns 12,775 shares in the company, valued at $421,319.50. The trade was a 20.20 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Joshua Foukas sold 5,732 shares of the business’s stock in a transaction that occurred on Wednesday, March 12th. The shares were sold at an average price of $32.54, for a total value of $186,519.28. The disclosure for this sale can be found here. Over the last three months, insiders have sold 15,920 shares of company stock valued at $500,285. 0.33% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On USANA Health Sciences

Institutional investors have recently added to or reduced their stakes in the business. KBC Group NV lifted its holdings in USANA Health Sciences by 96.6% in the 3rd quarter. KBC Group NV now owns 1,056 shares of the company’s stock worth $40,000 after buying an additional 519 shares during the period. Royce & Associates LP grew its holdings in shares of USANA Health Sciences by 22.2% in the third quarter. Royce & Associates LP now owns 33,143 shares of the company’s stock worth $1,257,000 after acquiring an additional 6,031 shares during the period. Quest Partners LLC bought a new stake in shares of USANA Health Sciences in the third quarter worth $250,000. Pzena Investment Management LLC grew its holdings in USANA Health Sciences by 7.5% during the third quarter. Pzena Investment Management LLC now owns 1,049,610 shares of the company’s stock valued at $39,801,000 after purchasing an additional 72,977 shares during the period. Finally, Pacer Advisors Inc. grew its holdings in USANA Health Sciences by 16.5% during the third quarter. Pacer Advisors Inc. now owns 544,256 shares of the company’s stock valued at $20,638,000 after purchasing an additional 76,904 shares during the period. 54.25% of the stock is currently owned by institutional investors.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.